Results

Total Results: 1,455 records

Showing results for "analyze".

  1. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-270-bimp-disposition-comments.pdf
    September 18, 2024 - One commenter was concerned about our components approach to analyze data for Key Question 1. … The hardest problem in our review was to determine how to analyze studies that used many of the same … One approach, taken by the related Sharpe Cochrane review, would have been to analyze all behavioral … The other extreme would be to analyze each treatment combination on its own (e.g., first a section on
  2. effectivehealthcare-admin.ahrq.gov/health-topics/peritoneal-disorders
    Cancer Complications from peritoneal dialysis Your doctor may use imaging tests or lab tests to analyze
  3. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/medical-test-reviews-meta-analysis.ppt
    June 01, 2012 - Deciding Which Metrics To Meta-analyze (1 of 6) Trikalinos TA, Coleman CI, Griffith L, et al. … Why does it make sense to directly meta-analyze sensitivity and specificity? … Deciding Which Metrics To Meta-analyze (3 of 6) Trikalinos TA, Coleman CI, Griffith L, et al. … Rarely is it meaningful to meta-analyze each value across studies. … Deciding Which Metrics To Meta-analyze (4 of 6) It is less helpful to meta-analyze predictive values
  4. effectivehealthcare-admin.ahrq.gov/sites/default/files/medical-test-reviews-meta-analysis.ppt
    June 01, 2012 - Deciding Which Metrics To Meta-analyze (1 of 6) Trikalinos TA, Coleman CI, Griffith L, et al. … Why does it make sense to directly meta-analyze sensitivity and specificity? … Deciding Which Metrics To Meta-analyze (3 of 6) Trikalinos TA, Coleman CI, Griffith L, et al. … Rarely is it meaningful to meta-analyze each value across studies. … Deciding Which Metrics To Meta-analyze (4 of 6) It is less helpful to meta-analyze predictive values
  5. effectivehealthcare-admin.ahrq.gov/products/methods-guidance-applicability/slides
    January 01, 2020 - This presentation focuses on assessing applicability, a task in the fourth of five steps, "Analyze and
  6. effectivehealthcare-admin.ahrq.gov/products/methods-guidance-grading-evidence/slides
    January 01, 2020 - This presentation focuses on grading the strength of evidence, a task in the fourth of five steps, "Analyze
  7. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/search-strategy-white-paper.pdf
    February 01, 2025 - Below are the narrative sections of the review form: • What to analyze: Entire record | Title Field … | Abstract Field | Subject Field • Methods to analyze: Boolean/Truncation support? … These steps lend themselves to tools that analyze structured bibliographic records using word frequency … evaluation (Table 5) and deduplication (Table 8) steps also include a number of useful tools that analyze … COMMENTS: While this tool does analyze the results of a search and provide counts of words and phrases
  8. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/models-care-adult-survivors-childhood-cancer-evidence-summary.pdf
    February 01, 2022 - researchers) and conducted targeted and iterative searching to (1) identify models of survivorship care and analyze … identify available tools, training, and other resources for childhood cancer survivorship care and analyze
  9. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cannabis-2022-update-surv-rep-1-app-F1-4.xlsx
    January 01, 2022 - F-1. Can. Study Characteristics Table F-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race, Hispanic/Latino % Race, Asian % Race, Other % P…
  10. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cannabis-app-f1-f4-tables-surveillance-report-2_0_0.xlsx
    February 16, 2022 - F-1. Can. Study Characteristics Table F-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race, Hispanic/Latino % Race, Asian % Race, Other % P…
  11. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-tables-e1-e4-2022-update_0.xlsx
    January 01, 2022 - E-1. Can. Study Characteristics Table E-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race, Hispanic/Latino % Race, Asian % Race, Other % P…
  12. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/Appendix-E-Evidence-Tables-E1-E4_0.xlsx
    November 04, 2021 - E-1. Can. Study Characteristics Table E-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race, Hispanic/Latino % Race, Asian % Race, Other % P…
  13. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/app-e-surv-report-2-nonopioid-pharmacol-chronic-pain.xlsx
    September 20, 2022 - NPP Table E-1. Neuropathic pain study characteristics Author, Year Country Trial Type Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized N Analyzed Intervention Duration (Weeks) Funding Source Hussain, 2021 Pakistan Placebo-controlled Fair NPP (DPN) Age, mean: 45 Female: 0% R…
  14. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-1-app-F.xlsx
    January 01, 2023 - F-1. Can. Study Characteristics Table F-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…
  15. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-tables-E-1-E-4.xlsx
    January 01, 2023 - E-1. Can. Study Characteristics Table E-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…
  16. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-4-tables-F1-4.xlsx
    January 01, 2022 - F-1. Can. Study Characteristics Table F-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…
  17. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-tables-F1-4.xlsx
    January 01, 2022 - F-1. Can. Study Characteristics Table F-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…
  18. effectivehealthcare-admin.ahrq.gov/products/patient-outcomes-symposium/overview
    November 01, 2018 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …
  19. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/app-e-surv-report-1-nonopioid-pharmacol-chronic-pain.xlsx
    September 20, 2022 - NPP Table E-1. Neuropathic pain study characteristics Author, Year Country Trial Type Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized N Analyzed Intervention Duration (Weeks) Funding Source Hussain, 2021 Pakistan Placebo-controlled Fair NPP (DPN) Age, mean: 45 Female: 0% R…
  20. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2024-surv-rep-update-tables-e1-4.xlsx
    January 01, 2024 - E-1. Can. Study Characteristics Table E-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: